Holmium Laser Enucleation of the ProstateBipolar Enucleation of the Prostate
Holmium Laser Enucleation of the Prostate: Enucleation of the prostate gland using holmium laser energy
Bipolar Enucleation of the Prostate: Enucleation of the prostate gland using bipolar energy
Study summary
This is a non-inferiority prospective randomized comparative clinical trial aiming to prove the non-inferiority of bipolar enucleation of the prostate in comparison to holmium laser enucleation of the prostate in management of benign prostatic hyperplasia patients with large prostates and in turn its feasibility as an alternative procedure in hospitals with limited resources
Eligibility
Sex
MALE
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age \>50 years
* Prostate volume \>80 ml
* Failure of or noncompliance with medical treatment
* IPSS \>15
* Qmax \<15 ml/sec
* Urinary retention and fixed catheters with poor results on trial of voiding without catheter
Exclusion Criteria:
* Patients with active UTI
* Prostate cancer
* Bladder carcinoma
* Urethral stricture
* Neurogenic bladder disorders
* Redo cases
Primary outcome measure(s)
Change in peak flow rate — At 6 months after the procedure (HoLEP or BipolEP) Treatment efficacy will be evaluated by comparing the change in peak flow rate (Qmax) on uroflowmetry between the two groups
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.